trending Market Intelligence /marketintelligence/en/news-insights/trending/q9IIVpCc0UNVIa9yv7uRcg2 content esgSubNav
In This List

RXi Pharmaceuticals names board member

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


RXi Pharmaceuticals names board member

RXi Pharmaceuticals Corp. appointed Jonathan Freeman to its board as an independent director, with immediate effect.

Freeman also serves as the chief business officer of privately held Vedanta Biosciences.